BILLERICA, Mass.–Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the Jefferies 2017 London Healthcare Conference on November 15, 2017, at 9:20am local London time.
To listen to a live audio webcast of the presentation, please visit http://investors.insulet.com/. A replay of the webcast will also be available following the event.
About Insulet Corporation:
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Insulet seeks to expand the use of insulin pump therapy with its Omnipod Insulin Management System among people with insulin-dependent diabetes. The Omnipod System is a revolutionary and easy-to-use tubeless insulin pump that provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's Delivery Systems business partners with global pharmaceutical and biotechnology companies to adapt the Omnipod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.
Latest posts by Maria Burns (see all)
- Servcorp Limited Announces FY2018 Interim Results - February 25, 2018
- Sicuro Group Granted ISO 27001 Accreditation in Dubai - February 25, 2018
- TIM and Cisco Join Forces To Increase The IT Security Of Italian Companies - February 25, 2018